Kevin M. Slawin, Chief Technology Officer at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 44,562 shares at $13.72 ($611K) on 2016-07-15, disclosed to the SEC on 2016-07-19.
Open-market sale of $611k BLCM by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.72 | 22,281 | $306K | 50.0% |
| 2 | $13.72 | 22,281 | $306K | 50.0% |
| Total | $13.72 avg | 44,562 | $611K | 100% |
| Filing → |
| BLCM | SELL | 2016-09-23 | $936K | — | Filing → |
| BLCM | SELL | 2016-09-20 | $92K | — | Filing → |
| BLCM | SELL | 2016-08-17 | $2.0M | — | Filing → |